X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


最新的帖子

六月 27, 2019

Industry Trends in Biologic Formulations

In 2018, we saw a record-setting year for new-molecular entity (NME) approvals (59) at the FDA1 versus 46 in 2017. 58% were for orphan drugs (patient population less than 200,000 in the US) with 17 biologic-based NME’s. Biosimilars are gaining traction in Europe, in particular. Major factors that are driving the market growth are next-generation business, high growth in chronic diseases, less expensive biosimilar drugs and favorable government regulations.
Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

以前的博客
West FluroTec barrier film coating

一月 29, 2019

Effective Drug Protection for Plungers in a Prefillable Syringe System

Christa Jansen-Otten

Christa Jansen-Otten

Director, Product Management, PFS & Delivery Systems

Prefillable Syringe Components

十一月 26, 2018

Addressing the Demands of Modern Drug Delivery Systems

Royce Brockett

Royce Brockett

Director, Product Management, PFS

Introducing Integrated Solutions

十月 08, 2018

Introducing Integrated Solutions

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

Load more